IVGIX | VVIAX | IVGIX / VVIAX | |
Total Expense Ratio | 0.64 | 0.05 | 1,280% |
Annual Report Gross Expense Ratio | 0.64 | 0.05 | 1,280% |
Fund Existence | 19 years | 25 years | - |
Gain YTD | -11.097 | 9.274 | -120% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 156M | 203B | 0% |
Annual Yield % from dividends | 3.46 | 2.10 | 164% |
Returns for 1 year | -7.02 | 8.78 | -80% |
Returns for 3 years | -0.68 | 37.31 | -2% |
Returns for 5 years | 21.77 | 74.86 | 29% |
Returns for 10 years | -6.51 | 134.06 | -5% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTTEX | 14.38 | -0.03 | -0.21% |
Fidelity Advisor Total Intl Equity M | |||
PRPPX | 15.99 | -0.04 | -0.25% |
Principal International Equity R3 | |||
CLTIX | 16.90 | -0.07 | -0.41% |
Catalyst/Lyons Tactical Allocation I | |||
RTOUX | 43.25 | -0.54 | -1.23% |
Russell Inv Tax-Managed US Mid&Sm Cap M | |||
SCURX | 31.54 | -0.50 | -1.56% |
Hartford Schroders US Small Cap Opps SDR |